Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

ACCESS Newswire

ACCESS Newswire

We are ACCESS Newswire, a globally trusted Public Relations (PR) and Investor Relations (IR) solutions provider. With a focus on innovation, customer service, and value-driven offerings, ACCESS Newswire empowers brands to connect with their audiences where it matters most. From startups and scale-ups to multi-billion-dollar global brands, we ensure your most important moments make an impact and resonate with your audiences.

Results: 445-456 of 1841

ACCESS Newswire logo

Reco Raises $30M B Round for a Total of $85M to Meet Rapidly Growing Demand for AI SaaS Security Among Enterprises

ACCESS Newswire logo

Logista Strator and Shekel Sign an Agreement to Bring Innovendi Elite to Spain - The Autonomous Sales Solution That Boosts Sales

ACCESS Newswire logo

Datavault AI Recaps High-Impact Super Bowl LX Weekend with NFL Alumni, Live ADIO(R) Activations, DVHOLO(TM) and Tokenization

ACCESS Newswire logo

Ore Energy Completes EU-Funded Multi-Day Energy Storage Pilot At EDF R&D Laboratories In France

ACCESS Newswire logo

RE Royalties Announces Second Tranche Investment of $800,000 in Solaris Energy's U.S. Distributed Generation Solar Portfolio

ACCESS Newswire logo

UK-Based Vesalic Limited Emerges from Stealth with Landmark Discovery of Potential Non-CNS Driver of Motor Neuron Diseases, including ALS, and Breakthrough Therapeutic and Diagnostic Opportunities

ACCESS Newswire logo

Innodata to Report Fourth Quarter and Fiscal Year 2025 Results

ACCESS Newswire logo

Datavault AI Chief Executive Officer and President Issues Letter to Stockholders Highlighting 2025 Accomplishments and Outlook for 2026

ACCESS Newswire logo

AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States

ACCESS Newswire logo

Preservica Redefines Digital Preservation with Powerful Built-In AI Tools

ACCESS Newswire logo

Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale

ACCESS Newswire logo

Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant

  • Prev Page
  • 1
  • 2
  • …
  • 37
  • 38
  • 39
  • …
  • 153
  • 154
  • Next Page

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us